This table lists all the major pharma collaborations, acquisitions and mergers agreed during August 2013.
For an indepth analysis of these deals, read ‘Pharma deals during August 2013’
| Licensor acquired / licensee acquirer | Deal type | Product / technology | Headline ($m) |
| Onyx Pharmaceuticals / Amgen | Acquisition | Cancer drugs including Kyprolis, Nexavar and Stivarga | 10,400 |
| Hi-Tech Pharmacal / Akorn | Acquisition | Develops, manufactures and markets generic and branded prescription and OTC products | 640 |
| Compugen / Bayer | Collaboration and licence agreement | Research, development, and commercialisation of antibody-based therapeutics for cancer immunotherapy against two novel checkpoint regulators | 540 |
| Amplimmune / AstraZeneca | Acquisition | AMP-514, a preclinical PD-1 monoclonal antibody. Other pipeline assets include several preclinical molecules targeting the B7 pathways | 500 |
| Systagenix / Kinetic Concepts | Merger and acquisition | Advanced wound care products | 485 |
| OptiMedica / Abbott | Acquisition | Ophthalmic device company | 400 |
| Thornton & Ross / Stada Arzneimittel | Acquisition | OTC manufacturer | 345 |
| Endosense / St Jude Medical | Acquisition | Catheter ablation | 331 |
| Medafor / C. R. Bard | Acquisition | Arista® MPH Hemostat | 280 |
| ProFibrix / The Medicines Company | Acquisition | Fibrocaps, dry powder haemostat | 240 |
| Boca Pharmacal / Qualitest | Acquisition | Speciality generics | 225 |
| ImmunoGen Inc / Lilly | Licence | Maytansinoid-based Targeted Antibody Payload (TAP) technology | 200.5 |
| Cardiocom / Medtronic | Acquisition | Remote monitoring devices and telehealth technologies | 200 |
| Crealta Pharmaceuticals / GTCR, Ed Fiorentino | JV | Speciality pharmaceuticals | 200 |
| Merck & Co / Avanir Pharmaceuticals | Co-promotion | Januvia, Janumet and Jamumet XR in nursing homes | 180 |
| GardenHills / Veropharm | Acquisition | Generic drug manufacture | 151 |
| Acton Pharmaceuticals / Meda | Acquisition | Respiratory medicines including the inhaled corticosteroid Aerospan™ (flunisolide) for the treatment of asthma | 135 |
| Theragenics / Jupiter | Acquisition | Surgical device manufacturer | 68 |
| Immco Diagnostics / Trinity Biotech | Acquisition | Development, manufacture and sale of autoimmune test kits | 33 |
| Pernix Therapeutics / Breckenridge Pharma | Acquisition | 11 Abbreviated New Drug Applications (ANDAs), certain ANDAs in various stages of development, 7 marketed products | 30 |